Tid Tittel Kategori Vedlegg
25.03.2026
08:00
 SoftOx Solutions AS: Fourth Quarter Report 2025 -
1
24.03.2026
21:36
 SoftOx Solutions AS: New Share Capital - -
11.03.2026
10:00
 SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited - -
03.03.2026
08:24
 SoftOx Solutions AS: First Subject Dosed in Combined Phase 2a Dose-Escalation and Proof-of-Concept Trial (SIS-03) - -
25.02.2026
08:00
 SoftOx Defense Solutions AS: HPRA Approves SIS-02 Phase 1 Trial, Strengthening Dual-Use and Preparedness Strategy - -
04.02.2026
12:43
 SoftOx Solutions AS: New Share Capital - -
23.01.2026
14:36
 SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited - -
29.12.2025
09:33
 SoftOx Solutions AS: Danish Medicines Agency Approves Phase 2a Trial for SoftOx Inhalation Solution - -
15.12.2025
10:23
 SoftOx Solutions AS: Minutes from the Extraordinary General Meeting -
1
05.12.2025
18:11
 SoftOx Solutions AS: New Share Capital - -
28.11.2025
14:32
 SoftOx Solutions AS: Notice of Extraordinary General Assembly -
1
28.11.2025
14:31
 SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited - -
26.11.2025
08:00
 SoftOx Solutions AS: Third Quarter Report 2025 -
1
14.11.2025
08:35
 SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured – Key Milestone for CF and EDF Clinical Programs - -
16.10.2025
12:26
 SoftOx Solutions AS: SoftOx submits Phase 1 Clinical Trial Application under the European Defence Fund (EDF) Program - -
13.10.2025
08:11
 SoftOx Solutions AS: New Share Capital - -
07.10.2025
21:17
 SoftOx Solutions AS: Private Placement resolved - -
03.10.2025
15:23
 SoftOx Solutions AS: New Share Capital - -
01.10.2025
14:35
 SoftOx Solutions AS: Clinical Trial Application for Dose Escalation / Cystic Fibrosis Phase 2a – Important Milestone Achieved - -